携带SOD1变异的肌萎缩侧索硬化患者的行为与认知表型
该研究连续纳入2012至2020年意大利运动神经元病中心的288例肌萎缩侧索硬化患者,比较携带SOD1变异者(14例)与无基因变异者(274例)的神经心理特征。两组认知损害比例均约60%,但SOD1阳性者按Strong标准定义的行为损害更常见,且主要与第5外显子变异相关,认知损害则主要见于SOD1阴性者。
要点
- SOD1阳性与阴性ALS患者认知损害比例均约60%,但SOD1阳性者行为损害更常见。
- SOD1阳性者行为损害以易激惹和精神僵化最常见,主要与第5外显子变异相关。
- 认知损害主要见于SOD1阴性患者;行为损害独立于年龄和疾病阶段。
核心结论
- 在深度表型的大样本ALS队列中,SOD1变异携带者的行为损害比既往认为的更常见,且独立于患者年龄和疾病阶段。
- 这些发现可能对临床试验结局评估和疾病管理有意义。
研究设计与样本
- 研究连续纳入2012至2020年意大利运动神经元病中心的ALS患者。
- 所有患者接受临床评估、评估认知功能与行为的广泛神经生理学测试组合,以及SOD1、FUS、TARDBP、VCP、PFN1、TUBA4A、OPTN、SQSTM1、UBQLN2和C9orf72基因的靶向下一代测序。
- 将SOD1阳性患者(n=14)的神经心理特征与无基因变异患者(SOD1阴性,N=274)进行比较。
- 收集按现行指南定义的认知和行为损害、基于意大利常模的异常测试表现数量以及额叶行为量表评分。
主要发现
- 在连续检查的288例患者中,于11个家系的14例ALS患者中鉴定出8个已知致病性SOD1变异和1个既往未描述的意义不确定变异(p.Ser26Asn)。
- 临床表型主要以下肢起病的下运动神经元受累为主,1例患者为延髓起病。
- SOD1阳性患者较SOD1阴性患者更年轻,两组功能运动残疾和疾病持续时间相似。
- 根据总体神经心理发现,SOD1阳性和SOD1阴性患者中异常表型的百分比均约为60%。
- 按Strong标准定义的行为损害(最常见为易激惹和精神僵化)在SOD1阳性患者中比SOD1阴性患者更常见,且主要与第5外显子变异相关;认知损害主要见于SOD1阴性患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: SOD1 variants in patients with amyotrophic lateral sclerosis (ALS) have been associated with peculiar clinical features and disease progression but rarely with cognitive and behavioral impairment. This study aims at describing the features of frontotemporal syndromes in patients with ALS carrying SOD1 variants. METHODS: Italian patients with ALS were consecutively enrolled between 2012 and 2020 at our Motor Neuron Disease Center. All underwent clinical assessment, extensive neurophysiologic test battery for the evaluation of cognitive functions and behavior, and targeted next-generation sequencing of SOD1, FUS, TARDBP, VCP, PFN1, TUBA4A, OPTN, SQSTM1, UBQLN2, and C9orf72 genes. Neuropsychological profiles of SOD1+ patients (SOD1+) were compared with those with no gene variants (SOD1-). To this aim, the occurrence of cognitive and behavioral impairment defined according to the current guidelines, the number of pathologic test performances based on Italian normative values, and scores of the Frontal Behavioral Inventory were collected. RESULTS: Among 288 patients consecutively examined, we identified 8 known pathogenic SOD1 variants and one variant of uncertain significance (p.Ser26Asn) not previously described in 14 patients with ALS belonging to 11 families. The clinical phenotypes were mainly characterized by predominant lower motor neuron involvement with onset at the lower limbs, and one patient had bulbar onset. SOD1+ patients (n = 14) were compared with SOD1- patients (N = 274). SOD1+ patients were younger than SOD1-, and both groups had similar functional motor disabilities and disease duration. Based on the overall neuropsychological findings, the percentage of SOD1+ and SOD1- patients with altered profiles were approximately 60%. However, behavioral impairment defined by the Strong criteria, and most commonly featuring with irritability and mental rigidity, was more frequent in SOD1+ than SOD1- patients and mainly associated with variants in exon 5. Conversely, cognitive impairment was mainly found in SOD1- patients. DISCUSSION: Our findings from a large cohort of deeply phenotyped patients with ALS demonstrated that behavioral involvement is more common than previously thought among patients harboring SOD1 variants and that it is independent from patients' age and disease stage. These findings could be relevant for the assessment of clinical trial outcomes and disease management.
引用
- Dalla Bella E, Bersano E, Bruzzone MG, et al. Behavioral and Cognitive Phenotypes of Patients With Amyotrophic Lateral Sclerosis Carrying SOD1 Variants. Neurology. 2022. PMID: 35985819. doi:10.1212/WNL.0000000000201044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。